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Premature mortality in refractory partial epilepsy:
does surgical treatment make a difference?
G S Bell,1 S Sinha,1 J de Tisi,1 C Stephani,2 C A Scott,1 W F Harkness,1
A W McEvoy,1 J L Peacock,3 M C Walker,1 S J Smith,1 J S Duncan,1
J W Sander1,4
ABSTRACT
Background Epilepsy carries an increased risk of
premature death. For some people with intractable focal
epilepsy, surgery offers hope for a seizure-free life. The
authors aimed to see whether epilepsy surgery
influenced mortality in people with intractable epilepsy.
Methods The authors audited survival status in two
cohorts (those who had surgery and those who had
presurgical assessment but did not have surgery).
Results There were 40 known deaths in the non-surgical
group (3365 person years of follow-up) and 19 in the
surgical group (3905 person-years of follow-up). Non-
operated patients were 2.4 times (95% CI 1.4 to 4.2) as
likely to die as those who had surgery. They were 4.5
times (95% CI 1.9 to 10.9) as likely to die a probable
epilepsy-related death. In the surgical group, those with
ongoing seizures 1 year after surgery were 4.0 (95% CI
1.2 to 13.7) times as likely to die as those who were
seizure-free or who had only simple partial seizures.
Time-dependent Cox analysis showed that the yearly
outcome group did not significantly affect mortality (HR
1.3, 95% CI 0.9 to 1.8).
Conclusion Successful epilepsy surgery was associated
with a reduced risk of premature mortality, compared
with those with refractory focal epilepsy who did not
have surgical treatment. To some extent, the reduced
mortality is likely to be conferred by inducing freedom
from seizures. It is not certain whether better survival is
attributable only to surgery, as treatment decisions were
not randomised, and there may be inherent differences
between the groups.
INTRODUCTION
Some patients with intractable focal seizures are
candidates for surgical treatment, which may be
curative. We assessed the survival of patients who
had surgery at the National Hospital for Neurology
and Neurosurgery (NHNN) and of patients who
were evaluated for epilepsy surgery but in whom
surgery was not performed.
METHODS
Surgical cohort
A prospective epilepsy surgery register has been
kept at NHNN since 1989 for continuing audit. At
annual follow-up, the seizure outcome group for
the previous 12 months is recorded using the ILAE
epilepsy surgery outcome scale.1 Patients in group 1
are completely seizure-free, and those in group 2
may have ‘auras.’ Groups 3e6 have increasingly
more seizures. In the analyses we considered those
in groups 1 and 2 as ‘seizure-free,’ to enable
comparison with other published cohorts. The
duration of follow-up was estimated from the date
of surgery and the date of death, or the date last
known to be alive.
Non-surgical cohort
A register is also kept of patients evaluated for
epilepsy surgery. Those who did not have surgery
included those deemed unsuitable after investiga-
tions, those who declined, those who died before
surgery and those who were still awaiting surgery.
Individual follow-up was obtained. The duration of
follow-up was calculated from the time of initial
presurgical evaluation until the date of death, or the
date at which each patient was known to be alive.
ANALYSIS
Person-years of follow-up were estimated for the
two groups. The age and duration of follow-up
were compared using the KruskaleWallis test. Age
at time of surgery or investigation (non-operated
group) was divided into ﬁve groups (<25 years,
N¼221; 25e29 years, N¼251: 30e34 years,
N¼225; 35e41 years, N¼255; $42 years, N¼249).
Age was unknown for one patient.
Those who had surgery were divided into groups
based on seizure outcome group at the ﬁrst year
after surgery and when last seen (outcome group
1 or 2, outcome group 3e6). Patients were further
grouped according to whether they remained
seizure-free (outcome group 1 or 2) or not seizure-
free (outcome group 3e6) throughout follow-up, or
whether they moved between these two groups.
Cox regression analysis was performed
comparing total mortality, epilepsy-related death
and sudden unexplained death in epilepsy (SUDEP)
in those who had surgery with those who did not,
and comparing mortality in those seizure-free
(group 1 or 2) with those not seizure-free at ﬁrst
year after surgery and at last contact. The strength
of relationship was estimated by HRs and 95% CIs;
a 95% CI which excludes 1.00 indicates a statisti-
cally signiﬁcant result.
Cox regression was performed to compare those
with variable outcome (varying between seizure-
free and not seizure-free) and those with seizures
throughout follow-up with those seizure-free
(group 1 and 2) throughout follow-up. A Cox-
model with time-dependent covariates (with an
interaction term between year and outcome class)
was used to assess the inﬂuence of seizure recur-
rence on mortality.
Analysis was performed in Stata MP/10.
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This audit was approved by the Joint Ethics Committee of
NHNN and the Institute of Neurology.
RESULTS
Patients
The non-surgical patients were slightly older than the surgical
patients and had a shorter median length of follow-up (table 1).
Those with surgery were aged between 16 and 64 years. The
maximum follow-up was 17.4 years. In 30 people, follow-up
was less than 0.8 years; six died (two of SUDEP, one of cancer,
one from a non-epilepsy-related accident, one of suicide and one
of infection). An additional 16 people have no outcome groups.
In 46 patients, we have only one outcome group; two died, both
of cancer.
The pattern of outcome groups and deaths for the remaining
patients is shown in table 2.
The non-surgical group were aged 15e71 years. Twenty-ﬁve
patients (3.9%) had no recorded follow-up (some live overseas)
and are excluded from the analysis. The maximum follow-up
duration is 15.4 years. Of the 40 (6.2%) known deaths, 20 died of
SUDEP, two of possible SUDEP, one drowned, one died in status,
one committed suicide, three died of cancer, ﬁve died of other
unrelated conditions, and in seven the cause of death was
unknown to us.
We classiﬁed those dying of SUDEP, drowning and status as
having probable epilepsy-related deaths (N¼24 for the non-
surgical group and 7 for the surgical group).
Survival in the non-surgical and surgical patients
Those who did not have surgery were more than twice as likely
to die during follow-up (HR 2.5; 95% CI 1.5 to 4.4). Neither
gender nor age affected the analysis (HR adjusted for age group
and gender 2.4, 95% CI 1.4 to 4.2). Age group did not affect
outcome independently, although gender affected the outcome
on a time-dependent basis.
Those in the non-surgical group were more likely to die from
a probable epilepsy-related death than those in the surgical
group (HR 4.6; 95% CI 1.9 to 11.0); this was unaffected by
gender or age group (adjusted HR 4.5, 95% CI 1.9 to 10.9). For
SUDEP and possible SUDEP, HR¼4.1 (95% CI 1.7 to 9.9).
Survival by seizure outcome class in surgical patients
Patients with a follow-up of less than 0.8 years (including six
who died) and those with unknown outcome are excluded from
the subsequent analyses which are dependent on the seizure
outcome group. At the end of the ﬁrst year, 369 were in outcome
group 1 or 2 (four deaths), and 146 were in outcome group 3e6
(nine deaths); those in outcome group 3e6 were 4.8 (95% CI 1.5
to 15.9) times as likely to die as those in group 1 or 2. This was
affected only slightly by gender or age group at surgery (adjusted
HR 4.0, 95% CI 1.2 to 13.7). At last review, 365 were in outcome
group 1 or 2 (six deaths) and 150 in group 3e6 (seven deaths).
Those in outcome group 3e6 were 2.3 (95% CI 0.8 to 6.9) times
as likely to die as those in group 1 or 2.
Throughout follow-up, 287 remained in group 1 or 2 (three
deaths), 94 remained in group 3e6 (six deaths) and 134 moved
between those two groups (four deaths); those consistently in
group 3e6 were 4.9 (95% CI 1.2 to 20.3) times as likely to die as
those remaining in group 1 or 2. The HR became non-signiﬁcant
after adjustment for age-group and gender (adjusted HR 4.0
(95% CI 0.97 to 16.6)).
The time-dependent Cox analysis showed a weak relationship
between yearly outcome group and mortality which did not
reach statistical signiﬁcance (HR 1.29, 95% CI 0.93 to 1.8). The
interaction term was not signiﬁcant (p¼0.8), showing no
evidence that the mortality risk varied with time.
No analysis was performed within the surgical group for
epilepsy-related deaths, as only ﬁve such deaths occurred in
people with seizure outcome data (table 2).
DISCUSSION
We found that those with refractory focal epilepsy who had
surgery had a lower risk of premature death than those who did
not. Short-term follow-up of epilepsy surgery generally shows
a beneﬁcial effect.2e5 Seizure status is not always constant over
time,3 4 6e12 and this may affect mortality.
In a randomised controlled trial, 80 patients with temporal
lobe epilepsy were randomised to surgical or medical treatment
for 1 year; the only death was SUDEP in a medically treated
patient.13 Another study matched 201 surgical patients with 185
retrospective controls and found no difference in survival, even
in a subgroup of 38 patients with controls who could have been
surgical candidates.14 In common with other studies, we found
that those who did not have surgery had shorter survival times
than those who did15 16
Our results are similar to a study in surgical patients which
reported three deaths in 148 patients who were seizure-free
(Engel class I) throughout follow-up and eight deaths in 67
patients not seizure-free.17 Another study reported one death in
258 patients with no recurrences and 18 deaths in 325 people
with recurrences.18
Those with a poor outcome at 1 year were more likely to die
than those with good outcome. The outcome group at last
follow-up, however, seemed less likely to predict death. No
analysis was performed using three groups (non-surgical,
surgical with good outcome and surgical with poor outcome), as
Table 1 Patient demographics
Non-surgical Surgical p Value
N (males) 641 (309) 561 (262)
Median (IQR) age at operation or
assessment in years
33.4 (27.3 to 41.2) 31.9 (26.4 to 39.0) 0.02
Median (IQR) follow-up in years 5.0 (2.6 to 8.4) 6.8 (3.1 to 10.7) 0.0001
Total follow-up (years) 3365 3905
Deaths 40 (1 in 84 years) 19 (1 in 206 years)
Epilepsy-related deaths 24 (1 in 140 years) 7 (1 in 558 years)
Table 2 Causes of death in patients according to common patterns of
outcome
Pattern N Deaths Cause of death
Constant outcome: seizure-free 209 2 Cancer (2)
Constant outcome: never seizure-
free
61 4 Cardiac failure, SUDEP (3)
Initially seizure-free, then seizures 44 1 Cancer
Initially seizures, then seizure-free 58 3 Cardiac problems, unknown,
SUDEP
Initially and finally seizure-free,
with seizures intervening
34 0
Complex pattern: never seizure-
free
21 1 SUDEP
Complex pattern, including
seizure freedom
42 0
Total 469 11
In the fifth group (initially and finally seizure-free, with seizures intervening) the transient
seizures were frequently caused by stopping AEDs, or by another temporary precipitant.
Seizure-free: outcome group 1 or 2; seizures: outcome groups 3e6.
SUDEP, sudden unexplained death in epilepsy.
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six deaths in the surgical group would be discounted (as death
occurred before an outcome group was deﬁned) leading to bias.
Time-dependent analysis showed that the relationship between
outcome group and mortality was weak, with no evidence at all
that this varied with time. The lack of signiﬁcance of the last
outcome group and of the time-dependent analysis may be
related to the small number of deaths (13). Despite a long
follow-up, the power is limited by the small numbers of deaths
and hence large HRs.
One limitation is the difference in follow-up between the
groups. Cox regression, however, makes allowance for incom-
plete follow-up, with those who are ‘lost’ being followed up to
the time at which they were last known to be alive.
Many epilepsy-related causes of death are more common in
people with higher seizure frequencies,19 and surgery is
frequently successful in abolishing seizures. Some of the differ-
ence in mortality between those suitable for surgery and those
not, and between those who have good seizure outcome and
those who do not, however, may be due to intrinsic differences
in the patients and their epilepsies, rather than the effects of
surgery.20 21
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